Abbott Diabetes Care Inc. et al. vs DexCom, Inc.

EXPUNGED

Petitioner's Notice of Appeal/Cross-Appeal

Patent Owner's Notice of Appeal

JUDGMENT Final Written Decision Determining Some of the Challenged Claims Unpatentable 35 U.S.C. § 318(a)

Ex. 3001

Other: Hearing transcript

Petitioner's Oral Argument Demonstratives

Patent Owner's Demonstrative Exhibits

Notice of Filing Patent Owner's Demonstrative Exhibits

Patent Owner's Fourth Updated Mandatory Notices

Order: Setting Oral Argument

Request to Substitute Exhibits 2006 & 2013

A. Kamath, A. Mahalingam and J. Brauker, “Methods of Evaluating the Utility of Continuous Glucose Monitor Alerts”, Journal of Diabetes Science and Technology, Vol. 4, Issue 1, January 2020 (“Kamath”) [CORRECTED]

Deposition Transcript of David Rodbard, taken January 18, 2023 [CORRECTED]

Petitioner's Request for Oral Argument

Patent Owner's Request for Oral Argument

Patent Owner's Third Updated Mandatory Notices

Patent Owner's SurReply

Deposition Transcript of David Rodbard, taken May 24, 2023 ("Rodbard-Reply-Dep.")

Notice of Deposition of Dr. David Rodbard

Petitioner's Updated Exhibit List

Patent Owner's Objections to Evidence Served with Petitioenr's Reply

Petitioner's Reply to PO Response

Keenan depo transcript

Supplemental Declaration of Dr. Rodbard

GlucoWatch® G2™ Biographer (GW2B) Alarm

Patent Owner's Second Updated Mandatory Notices

Petitioner's Notice of Deposition of Dr. Barry Keenan

Petitioner's Objections to Evidence Submitted with Patent Owner's Response

A. Kamath, A. Mahalingam and J. Brauker, “Methods of Evaluating the Utility of Continuous Glucose Monitor Alerts”, Journal of Diabetes Science and Technology, Vol. 4, Issue 1, January 2020 (“Kamath”)

Glucose level graph from deposition of David Rodbard

Resume of Barry Keenan, Ph.D, MBA, PMP

Excerpt of A Dictionary of Computing, Sixth Edition, Oxford University Press (2008) (“Oxford”)

Printout of https://web.archive.org/web/20061123145947/https:/www.broadcaststore.com/store/model_detail.cfm?id=18790

Deposition Transcript of David Rodbard, taken January 18, 2023

Abbott Freestyle Navigator Continuous Glucose Monitoring System: User’s Guide

Medtronic User Guide: Guardian Real-Time Continuous Glucose Monitoring System

Memorandum Opinion, Abbott Diabetes Care Inc., et al. v. DexCom Inc. Case No. 21-1699 (KAJ) (District of Del. Nov. 29, 2022)

Declaration of Barry Keenan

Patent Owner Response

Amended Notice of Deposition of Dr. David Rodbard

Notice of Deposition of Dr. David Rodbard

Petitioner's Updated Exhibit List

Patent Owner's Objections to Evidence

Petitioner's Updated Mandatory Notices

Institution Decision: Grant

SCHEDULING ORDER

Petitioner's Updated Mandatory Notices

Petitioner's Updated Exhibit List

Exhibit 1032 - Amended Scheduling Order

July 7, 2022, e-mail from [email protected]

Patent Owner's Sur-Reply in Support of Preliminary Response

Petitioner's Authorized Reply to Patent Owner's Preliminary Response

DexCom's Rejoinder (excerpted)

DexCom's Replica (excerpted)

Claimants' Response to Defendants' Third Notice to Admit Facts

Amended Grounds of Invalidity

USP 9,119,528

Patent Owner's Preliminary Response

U.S. Patent App. Pub. No. 2011/0131307 ("Bazzal")

U.S. Patent App. Pub. No. 2012/0185416 ("Baras")

U.S. Patent App. Pub. No. 2007/0107973 ("Jiang")

U.S. Patent App. Pub. No. 2005/0280521 ("Mizumaki")

Patent Owner's First Updated Mandatory Notices

PETITIONER'S UPDATED MANDATORY NOTICES UNDER 37 C.F.R. 42.8(a)(3)

Power of Attorney

Patent Owner's Mandatory Notices

Notice filing date accorded

Power of Attorney

U.S. Patent No. 10,702,215 ("'215 Patent")

Prosecution File History of the '215 Patent

DexCom STS Continuous Glucose Monitoring System User's Guide ("User's Guide" or "Guide")

U.S. Pub. No. 2011/0193704 to Harper ("Harper")

Stefania Guerra et al., A Dynamic Risk Measure from Continuous Glucose Monitoring Data, DIABETES TECHNOLOGY & THERAPEUTICS, 13(8), 843-852 (Aug. 2011) ("Guerra")

U.S. Pub. No. 2009/0192380 to Shariati ("Shariati")

U.S. Pat. No. 6,565,509 to Say ("Say")

William Clarke et al., Statistical Tools to Analyze Continuous Glucose Monitor Data, DIABETES TECHNOLOGY & THERAPEUTICS, 11(1), S-45-54 (Jun. 2009) ("Clarke")

Declaration of Duncan Hall

Declaration of Sylvia D. Hall-Ellis, Ph.D.

Excerpts of Plaintiff DexCom, Inc.'s Preliminary Disclosure of Asserted Claims and Infringement Contentions, DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690-ADA (W.D. Tex. June 30, 2021)

International Standard: Medical electrical equipment Part 1-8, CEI IEC 60601-1-8, Second Edition, 2006-10

Premarket Approval (PMA), Device: DexCom STS Continuous Monitors, https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P050012 (last visited Apr. 21, 2022)

JPMorgan, North America Equity Research, Diabetes Care ADA 2006: Spotlight On Continuous Glucose Monitoring (June 11, 2006)

Kovatchev et al., Symmetrization of the Blood Glucose Measurement Scale and Its Applications, DIABETES CARE, 20(11), 1655-58 (Nov. 1997)

David Rodbard et al., A semilogarithmic scale for glucose provides a balanced view of hyperglycemia and hypoglycemia, J. DIABETES SCI., 3(6), 1395-1401 (Nov. 2009)

Buckingham et al., Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension, Diabetes Care, DIABETES CARE, 33(5), 1013-17 (May 2010)

Kovatchev et al., Risk Analysis of Blood Glucose Data: A Quantitative Approach to Optimizing the Control of Insulin Dependent Diabetes, JOURNAL OF THEORETICAL MEDICINE, 3(1), 4-1-10 (Jan. 2000)

DexCom, Inc.'s Proposed Claim Constructions, DexCom, Inc. v. Abbott Diabetes Care Inc. et al., No. 6:21-cv-690-ADA (W.D. Tex. Feb. 22, 2022)

Lex Machina Data on Schedule of Judge Albright in the Western District of Texas

Andrew T. Dufresne, Nathan K. Kelley, & Lori Gordon, How reliable are trial dates relied on by the PTAB in the Fintiv analysis?, PERKINS COIE 1600 PTAB & BEYOND, Oct. 29, 2021

Dani Kass, Fintiv Fails: PTAB Uses 'Remarkably Inaccurate' Trial Dates, LAW360, Nov. 2, 2021

Plaintiff's Responsive Claim Construction Brief, Dexcom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690-ADA, Dkt. 98 (W.D. Tex. Apr. 8, 2022)

Email Chain Between Defendants' Litigation Counsel and DexCom's Litigation Counsel re DexCom's Identification of Asserted Claims in DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690 (W.D. Tex.) (Nov. 30, 2021 - Jan. 5, 2022)

U.S. Pub. No. 2013/0109944 A1 ("Sparacino")

Declaration of Dr. David Rodbard

Petition for Inter Partes Review of U.S. Patent No. 10,702,215